364 related articles for article (PubMed ID: 19622357)
1. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Stoffel E; Mukherjee B; Raymond VM; Tayob N; Kastrinos F; Sparr J; Wang F; Bandipalliam P; Syngal S; Gruber SB
Gastroenterology; 2009 Nov; 137(5):1621-7. PubMed ID: 19622357
[TBL] [Abstract][Full Text] [Related]
2. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS
Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088
[TBL] [Abstract][Full Text] [Related]
3. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
Mukherjee B; Rennert G; Ahn J; Dishon S; Lejbkowicz F; Rennert HS; Shiovitz S; Moreno V; Gruber SB
Gastroenterology; 2011 Jun; 140(7):1919-26. PubMed ID: 21419771
[TBL] [Abstract][Full Text] [Related]
4. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
[TBL] [Abstract][Full Text] [Related]
5. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
6. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
Win AK; Lindor NM; Winship I; Tucker KM; Buchanan DD; Young JP; Rosty C; Leggett B; Giles GG; Goldblatt J; Macrae FA; Parry S; Kalady MF; Baron JA; Ahnen DJ; Marchand LL; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Jenkins MA
J Natl Cancer Inst; 2013 Feb; 105(4):274-9. PubMed ID: 23385444
[TBL] [Abstract][Full Text] [Related]
7. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
Boilesen AE; Bisgaard ML; Bernstein I
Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272
[TBL] [Abstract][Full Text] [Related]
8. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
9. Risk of pancreatic cancer in families with Lynch syndrome.
Kastrinos F; Mukherjee B; Tayob N; Wang F; Sparr J; Raymond VM; Bandipalliam P; Stoffel EM; Gruber SB; Syngal S
JAMA; 2009 Oct; 302(16):1790-5. PubMed ID: 19861671
[TBL] [Abstract][Full Text] [Related]
10. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
11. Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome.
Marques-de-Sá I; Castro R; Pita I; Dinis-Ribeiro M; Brandão C
Scand J Gastroenterol; 2020 Jun; 55(6):701-705. PubMed ID: 32448028
[No Abstract] [Full Text] [Related]
12. Cancer risks for MLH1 and MSH2 mutation carriers.
Dowty JG; Win AK; Buchanan DD; Lindor NM; Macrae FA; Clendenning M; Antill YC; Thibodeau SN; Casey G; Gallinger S; Marchand LL; Newcomb PA; Haile RW; Young GP; James PA; Giles GG; Gunawardena SR; Leggett BA; Gattas M; Boussioutas A; Ahnen DJ; Baron JA; Parry S; Goldblatt J; Young JP; Hopper JL; Jenkins MA
Hum Mutat; 2013 Mar; 34(3):490-7. PubMed ID: 23255516
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Wang CY; You JF; Hsiung CA; Yeh CC
PLoS One; 2015; 10(6):e0130018. PubMed ID: 26053027
[TBL] [Abstract][Full Text] [Related]
14. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
Parry S; Win AK; Parry B; Macrae FA; Gurrin LC; Church JM; Baron JA; Giles GG; Leggett BA; Winship I; Lipton L; Young GP; Young JP; Lodge CJ; Southey MC; Newcomb PA; Le Marchand L; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
Gut; 2011 Jul; 60(7):950-7. PubMed ID: 21193451
[TBL] [Abstract][Full Text] [Related]
15. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
[TBL] [Abstract][Full Text] [Related]
16. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.
Kastrinos F; Steyerberg EW; Mercado R; Balmaña J; Holter S; Gallinger S; Siegmund KD; Church JM; Jenkins MA; Lindor NM; Thibodeau SN; Burbidge LA; Wenstrup RJ; Syngal S
Gastroenterology; 2011 Jan; 140(1):73-81. PubMed ID: 20727894
[TBL] [Abstract][Full Text] [Related]
17. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Sampson JR; Capella G; Mecklin JP; Möslein G;
Gut; 2017 Mar; 66(3):464-472. PubMed ID: 26657901
[TBL] [Abstract][Full Text] [Related]
19. Risks of less common cancers in proven mutation carriers with lynch syndrome.
Engel C; Loeffler M; Steinke V; Rahner N; Holinski-Feder E; Dietmaier W; Schackert HK; Goergens H; von Knebel Doeberitz M; Goecke TO; Schmiegel W; Buettner R; Moeslein G; Letteboer TG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Wagner A; Kluijt I; Propping P; Vasen HF
J Clin Oncol; 2012 Dec; 30(35):4409-15. PubMed ID: 23091106
[TBL] [Abstract][Full Text] [Related]
20. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M
BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]